- Home
- CATX vs OSUR Comparison
CATX vs OSUR Comparison
Compare CATX & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- OSUR
- Stock Information
- Founded
- CATX 1983
- OSUR 2000
- Country
- CATX United States
- OSUR United States
- Employees
- CATX N/A
- OSUR N/A
- Industry
- CATX Medical/Dental Instruments
- OSUR Medical/Dental Instruments
- Sector
- CATX Health Care
- OSUR Health Care
- Exchange
- CATX Nasdaq
- OSUR Nasdaq
- Market Cap
- CATX 239.0M
- OSUR 229.7M
- IPO Year
- CATX N/A
- OSUR 1986
- Fundamental
- Price
- CATX $3.46
- OSUR $3.29
- Analyst Decision
- CATX Strong Buy
- OSUR Hold
- Analyst Count
- CATX 11
- OSUR 1
- Target Price
- CATX $12.90
- OSUR $3.00
- AVG Volume (30 Days)
- CATX 649.3K
- OSUR 618.4K
- Earning Date
- CATX 08-13-2025
- OSUR 08-05-2025
- Dividend Yield
- CATX N/A
- OSUR N/A
- EPS Growth
- CATX N/A
- OSUR N/A
- EPS
- CATX N/A
- OSUR N/A
- Revenue
- CATX $1,235,000.00
- OSUR $138,533,000.00
- Revenue This Year
- CATX N/A
- OSUR N/A
- Revenue Next Year
- CATX N/A
- OSUR $5.35
- P/E Ratio
- CATX N/A
- OSUR N/A
- Revenue Growth
- CATX N/A
- OSUR N/A
- 52 Week Low
- CATX $1.60
- OSUR $2.36
- 52 Week High
- CATX $16.31
- OSUR $4.61
- Technical
- Relative Strength Index (RSI)
- CATX 47.63
- OSUR 61.84
- Support Level
- CATX $3.42
- OSUR $2.76
- Resistance Level
- CATX $3.68
- OSUR $3.54
- Average True Range (ATR)
- CATX 0.24
- OSUR 0.15
- MACD
- CATX -0.01
- OSUR 0.07
- Stochastic Oscillator
- CATX 41.88
- OSUR 72.50
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.